A review conducted by Fumagalli et al. [58] analyzed the genetic profiles of patients and checked out the impacts on metabolism. They exclusively checked out human CHC22 clathrin, which performs a central role in intracellular targeted visitors of insulin-responsive glucose transporter four (GLUT4). The GLUT4 pathway may be the dominant system used